C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group

Patents for C07D 403 - Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group (62,587)
11/2011
11/17/2011	US20110281868 Indazole inhibitors of kinase
11/17/2011	US20110281851 Biphenyl compounds useful as muscarinic receptor antagonists
11/17/2011	US20110281849 Aryl Indolyl Sulfonamide Compounds and Their Use as 5-HT6 Ligands
11/17/2011	US20110281848 Imidazole compounds having pharmaceutical activity towards the sigma receptor
11/17/2011	US20110281843 Substituted indazole derivatives active as kinase inhibitors
11/17/2011	US20110281841 Kinase Inhibitors
11/17/2011	US20110281840 N-substituted saturated heterocyclic sulfone compounds with cb2 receptor agonistic activity
11/17/2011	US20110281838 5-alkynyl-pyrimidines
11/17/2011	US20110280804 Highly selective sigma receptor radioligands
11/17/2011	US20110279020 Biscarbazole Derivative, Material for Organic Electroluminescence Device and Organic Electroluminescence Device Using The Same
11/17/2011	CA2800578A1 Nitrogen-heterocyclic compounds as phosphodiesterase 10 inhibitors
11/17/2011	CA2799154A1 Indazole inhibitors of kinase
11/17/2011	CA2799146A1 Nitrogen-containing heterocyclic compound having inhibitory effect on production of kynurenine
11/17/2011	CA2799020A1 Heteroaryloxycarbocyclyl compounds as pde10 inhibitors
11/17/2011	CA2798697A1 Lipoic acid and nitroxide derivatives and uses thereof
11/17/2011	CA2798490A1 Nitrogen heterocyclic compounds useful as pde10 inhibitors
11/16/2011	EP2386553A1 Benzimidazole-4-carboxamide derivatives, their preparation methods, pharmaceutical compositions and their uses
11/16/2011	EP2386545A1 Heteroaryl ureas containing nitrogen hetero-atoms as P38 kinase inhibitors
11/16/2011	EP2385942A1 Benzimidazole and pyrazolopyridine derivatives for treating and/or preventing cardiovascular diseases
11/16/2011	EP2231679B1 Synthesis of biguanidines and triazines, and biguanidino-aluminium complexes as intermediates
11/16/2011	EP2142533B1 Imidazolidinone derivatives
11/16/2011	EP2086959B1 Substituted 2-imidazoles as modulators of the trace amine associated receptors
11/16/2011	EP1896452B1 N-formyl hydroxylamine compounds
11/16/2011	EP1727794B1 Novel benzyl(idene)-lactam derivatives
11/16/2011	CN102245599A New 4-amino-4-oxobutanoyl peptides as inhibitors of viral replication
11/16/2011	CN102245598A 4-amino-4-oxobutanoyl peptide cyclic analogues, inhibitors of viral replication
11/16/2011	CN102245597A Compounds useful for inhibiting CHK1
11/16/2011	CN102245596A Quinazolinamide derivatives
11/16/2011	CN102245595A Heterocyclic compound as protein kinase inhibitor
11/16/2011	CN102245580A Novel substrates of O6-alkylguanine-DNA alkyltransferase and mutants thereof
11/16/2011	CN102245181A Heterocyclic benzimidazoles as TRPM8 modulators
11/16/2011	CN102241672A 2,3-dipyrrolyl-6-acylaminoquinoxaline compounds and preparation method thereof
11/16/2011	CN102241637A 2,3-diphenyl-6-amido quinoxaline compound and preparation method thereof
11/16/2011	CN101516852B Quinoline derivatives with 5-ht-binding properties
11/16/2011	CN101448791B Fxr agonists
11/16/2011	CN101166529B Benzotriazole derivatives as cannabinoid receptor antagonists
11/15/2011	US8058550 Polymers with low band gaps and high charge mobility
11/15/2011	US8058452 Pyrazolyl-substituted heterocycles and their use as phytosanitary products
11/15/2011	US8058451 Enhanced solubility in common solvents; ion sensor; removal odors; water and air pollution control
11/15/2011	US8058450 Nitrogenous heterocyclic derivative and organic electroluminescence device making use of the same
11/15/2011	US8058288 Amido compounds and their use as pharmaceuticals
11/15/2011	US8058277 Substituted indoles
11/15/2011	US8058269 Oxindole derivatives
11/15/2011	CA2666975C Aminopyrazole derivatives, process for the preparation thereof, and composition for preventing or treating ischemic diseases containing the same
11/15/2011	CA2385736C Mediators of hedgehog signaling pathways, compositions and uses related thereto
11/10/2011	WO2011140190A1 Tetrazolones as inhibitors of fatty acid synthase
11/10/2011	WO2011139414A2 Dexlansoprazole polymorphic forms
11/10/2011	WO2011139022A2 Benzindocyanine compound used for substance marking, an intermediate production product thereof and a production method therefor
11/10/2011	WO2011138409A1 Combretastatin analogs for use in the treatment of cancer
11/10/2011	WO2011107530A3 Inhibitors of glutaminyl cyclase
11/10/2011	WO2011087316A3 Method for preparing tetrazole methanesulfonic acid salts, and novel compound used in same
11/10/2011	WO2011082269A3 Substituted benzo-pyrimido-tetrazolo-diazepine compounds
11/10/2011	WO2011081408A3 Imatinib dichloroacetate and anti-cancer agent comprising the same
11/10/2011	WO2011071314A3 Processes for preparing crystalline forms a and b of ilaprazole and process for converting the crystalline forms
11/10/2011	US20110275819 Organic compounds and their uses
11/10/2011	US20110275810 Carbamic acid compounds comprising a piperazine linkage as hdac inhibitors
11/10/2011	US20110275800 2-sulfonylamino-4-heteroaryl butyramide antagonists of ccr10
11/10/2011	US20110275690 New crystal form of sunitinib malate
11/10/2011	US20110275689 Preparation of 3-Pyrrole Substituted 2-Indolinone Derivatives
11/10/2011	US20110275676 Triazole-substituted anthranilamides as pesticides
11/10/2011	US20110275673 Inhibitors of sphingosine kinase 1
11/10/2011	US20110275671 Dihydroindolinone derivatives
11/10/2011	US20110275657 Melanocortin receptor modulators, process for preparing them and use there in human medicine and cosmetics
11/10/2011	US20110275633 2,4-diaminopyrimidine derivates as ptk2- inhibitors for the treatment of abnormal cell growth
11/10/2011	US20110275627 Indolizine inhibitors of leukotriene production
11/10/2011	US20110275612 Alpha-substituted n-sulfonyl gylcine amides antagonists of ccr10, compositions containing the same and methods for using them
11/10/2011	US20110275611 Chemical compounds
11/10/2011	US20110275607 Nuclear transport modulators and uses thereof
11/10/2011	US20110275590 Conjugates for cancer therapy and diagnosis
11/10/2011	US20110274655 Tetrazolones as inhibitors of fatty acid synthase
11/10/2011	US20110274648 Hepatitis C Virus Inhibitors
11/10/2011	US20110274638 Oxoazetidine derivatives, process for the preparation thereof and use thereon in human medicine and in cosmetics
11/09/2011	EP2385048A1 Hepatitis C virus inhibitors
11/09/2011	EP2385042A1 Prokineticin 1 receptor antagonists
11/09/2011	EP2385041A1 Pyrazole-amine compounds useful as kinase inhibitors
11/09/2011	EP2385039A1 2-Iminoisoindolinone derivatives as thrombin receptor antagonists
11/09/2011	EP2385038A1 Dimeric IAP inhibitors
11/09/2011	EP2385035A1 Preparation method of dihydroindene amide compounds their pharmaceutical compositions containg compounds thereof and use as protein kinases inhibitor
11/09/2011	EP2384753A1 Hydantoin derivatives as inhibitors of cellular necrosis
11/09/2011	EP2384320A2 Pyrrolidine compounds which modulate the cb2 receptor
11/09/2011	EP1667675B1 Entry inhibitors of the hiv virus
11/09/2011	EP1651620B1 Piperazine derivatives and their use as therapeutic agents
11/09/2011	EP1633740B1 5-(acylamino)indazole derivatives as kinase inhibitors
11/09/2011	EP1007513B1 Pesticidal 1-aryl-3-iminopyrazoles
11/09/2011	CN1934113B Compositions useful as inhibitors of protein kinases
11/09/2011	CN1845920B 2-amido-4-aryloxy-1-carbonylpyrrolidine derivatives as inhibitors of serine proteases, particularly HCV NS3-NS4A protease
11/09/2011	CN102239164A 2h-chromene compound and derivative thereof
11/09/2011	CN102239163A Sunitinib and salts thereof and their polymorphs
11/09/2011	CN102239162A Pyridazinone derivatives
11/09/2011	CN102239146A Novel compounds as calcium channel blockers
11/09/2011	CN102234266A Preparation and application of tetrahydrofolic acid ring-opened analogs with aziridine structure
11/09/2011	CN101684101B Piperazinone substituted tetracycline derivatives
11/09/2011	CN101405275B Triazolone derivative
11/09/2011	CN101343251B Thrombopoietin mimetics
11/08/2011	US8053564 Biological effectors; S-[3-({2-(3-{[3-(2,5-Dioxo-2,5-dihydro-1H-pyrrol-1-yl)propanoyl]amino}propoxy)-1,1-bis[3-{[3-(2,5-dioxo-2,5-dihydro-1 H-pyrrol-1-yl)propanoyl]amino}propoxy)methyl]ethyl}amino)-3-oxopropyl]ethanethioate
11/08/2011	US8053457 3-imidazolyl-indoles for the treatment of proliferative diseases
11/08/2011	US8053455 Angiotensin II receptor antagonists
11/08/2011	US8053445 Utilities of olefin derivatives
11/08/2011	US8053441 Pyrazolylquinazolinones as potassium channel openers
11/08/2011	US8053436 9-(piperazinylalkyl) carbazoles as bax-modulators

1 ... 92 93 94 95 96 97 98 99 100 101 102 103 104 105 106 107 108 109 110 111 112 ... 626